Publications

LeBlanc, TW, Sederstrom, N, Spence, R, and von Roenn, J. "Palliative Care Has Come of Age." Journal of oncology practice 13, no. 9 (September 2017): 589-590.

PMID
28829695
Full Text

Shah, JJ, Abonour, R, Gasparetto, C, Hardin, JW, Toomey, K, Narang, M, Srinivasan, S, Kitali, A, Zafar, F, Flick, ED, and Rifkin, RM. "Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes." Clinical lymphoma, myeloma & leukemia 17, no. 9 (September 2017): 575-583.e2.

PMID
28886839
Full Text

Muffly, L, Pasquini, MC, Martens, M, Brazauskas, R, Zhu, X, Adekola, K, Aljurf, M, Ballen, KK, Bajel, A, Baron, F, Battiwalla, M, Beitinjaneh, A, Cahn, J-Y, Carabasi, M, Chen, Y-B, Chhabra, S, Ciurea, S, Copelan, E, D'Souza, A, Edwards, J, Foran, J, Freytes, CO, Fung, HC, Gale, RP, Giralt, S, Hashmi, SK, Hildebrandt, GC, Ho, V, Jakubowski, A, Lazarus, H, Luskin, MR, Martino, R, Maziarz, R, McCarthy, P, Nishihori, T, Olin, R, Olsson, RF, Pawarode, A, Peres, E, Rezvani, AR, and Rizzieri, D et al. "Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States." Blood 130, no. 9 (August 2017): 1156-1164.

PMID
28674027
Full Text

Stover, JT, Shaw, JR, Kuchibhatla, M, Horwitz, ME, and Engemann, AM. "Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 23, no. 8 (August 2017): 1290-1294.

PMID
28411174
Full Text

LeBlanc, TW, Roeland, EJ, and El-Jawahri, A. "Early Palliative Care for Patients with Hematologic Malignancies: Is It Really so Difficult to Achieve?." Current hematologic malignancy reports 12, no. 4 (August 2017): 300-308. (Review)

PMID
28639084
Full Text

Batlevi, CL, Crump, M, Andreadis, C, Rizzieri, D, Assouline, SE, Fox, S, van der Jagt, RHC, Copeland, A, Potvin, D, Chao, R, and Younes, A. "A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma." British journal of haematology 178, no. 3 (August 2017): 434-441.

PMID
28440559
Full Text

Cruz-Oliver, DM, Bernacki, R, Cooper, Z, Grudzen, C, Izumi, S, Lafond, D, Lam, D, LeBlanc, TW, Tjia, J, and Walter, J. "The Cambia Sojourns Scholars Leadership Program: Conversations with Emerging Leaders in Palliative Care." Journal of palliative medicine 20, no. 8 (August 2017): 804-812.

PMID
28525294
Full Text

Vogl, DT, Martin, TG, Vij, R, Hari, P, Mikhael, JR, Siegel, D, Wu, KL, Delforge, M, and Gasparetto, C. "Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma." Leukemia & lymphoma 58, no. 8 (August 2017): 1872-1879.

PMID
28140719
Full Text

Boss, MK, Dewhirst, MW, Sampaio, RS, Bennett, A, Tovmasyan, A, Berman, KG, Beaven, AW, Rizzieri, DA, Batinic-Haberle, I, Hauck, ML, and Spasojevic, I. "Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy." Cancer chemotherapy and pharmacology 80, no. 2 (August 2017): 421-431.

PMID
28685347
Full Text

Huang, J, Chen, M, Whitley, MJ, Kuo, H-C, Xu, ES, Walens, A, Mowery, YM, Van Mater, D, Eward, WC, Cardona, DM, Luo, L, Ma, Y, Lopez, OM, Nelson, CE, Robinson-Hamm, JN, Reddy, A, Dave, SS, Gersbach, CA, Dodd, RD, and Kirsch, DG. "Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma." Nature communications 8 (July 10, 2017): 15999-.

PMID
28691711
Full Text

Pages